David Battersby

Team Leader, Associate Fellow GSK

Seminars

Tuesday 24th February 2026
Evolving ADC Discovery to Design & Develop Next-Generation ADCs with Differentiated Therapeutic Profiles
12:00 pm
  • Leveraging automation to improve efficiency and throughput for ADC discovery
  • Laying out the GSK approach and attitude to ADC discovery to ensure development of future ADC therapeutic impact
  • Highlighting novel linker-payload design approaches to improve ADC physicochemical properties and tumour targeting specificity
David Battersby Speaker Photo - 16th World ADC London Summit